Who Owns CTSO?

Cytosorbents Corporation — Institutional Ownership & 13F Holdings

$0.64

+0.03 (+5.38%)

Market Cap

$50.9M

Shares Outstanding

62,804,305

Institutional Holders

47

Total Inst. Value

$16.8M

% of Float Held

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

8

Closed Positions

10

Increased

17

Decreased

8

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1AVENIR CORP$5.0M5,044,918
2Skylands Capital, LLC$3.0M3,002,702
3VANGUARD GROUP INC$1.9M1,949,551
4Neuberger Berman Group LLC$1.7M1,679,628
5CM Management, LLC$954K954,076
6Sargent Investment Group, LLC$823K823,500
7BlackRock, Inc.$627K627,305
8GEODE CAPITAL MANAGEMENT, LLC$613K613,855
9Granahan Investment Management, LLC$358K358,418
10RENAISSANCE TECHNOLOGIES LLC$225K225,254

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CTSO?

As of Q1 2025, 47 institutional investors report holding CTSO (Cytosorbents Corporation) in their 13F filings.

Which hedge fund owns the most CTSO?

The largest institutional holder of CTSO is AVENIR CORP with $5.0M in shares.

Are institutions buying or selling CTSO?

This quarter, 8 institutions opened new positions in CTSO and 10 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.